This Week in HIV Research: Fentanyl Smooths the Path for HIV

This Week in HIV Research: Fentanyl Smooths the Path for HIV

1 of 5
Next >

We've got an effervescent potpourri of HIV-related research findings to share with you this week! In our latest review of newly published science of potential clinical note, we:

  • Learn more about what's driving the ongoing HIV outbreak in northeastern Massachusetts. (Hint: It rhymes with "sentinel." Also it's in the headline.)
  • Gain insight into significant race-gender disparities in HIV prevalence among sex workers in Baltimore.
  • Get a stark reminder of just how far we have to go -- but also how much potential there is -- in improving pre-exposure prophylaxis (PrEP) awareness and access among black women in the southern U.S.
  • Find out about the promise of a naltrexone implant as a possible replacement for oral drugs in the management of opioid dependence.

Let's sniff out some details from each of these interesting reports. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: Creatas Images via Thinkstock

We've got an effervescent potpourri of HIV-related research findings to share with you this week! In our latest review of newly published science of potential clinical note, we:

  • Learn more about what's driving the ongoing HIV outbreak in northeastern Massachusetts. (Hint: It rhymes with "sentinel." Also it's in the headline.)
  • Gain insight into significant race-gender disparities in HIV prevalence among sex workers in Baltimore.
  • Get a stark reminder of just how far we have to go -- but also how much potential there is -- in improving pre-exposure prophylaxis (PrEP) awareness and access among black women in the southern U.S.
  • Find out about the promise of a naltrexone implant as a possible replacement for oral drugs in the management of opioid dependence.

Let's sniff out some details from each of these interesting reports. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: Creatas Images via Thinkstock